StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.10−0.05 (-2.33%)

Close on Nov 17, 2026Market cap $115.02MP/E –Yield –

Upstream Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Upstream Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$168.33M. For fiscal 2025 it was -$133.28M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$133.28M–
FY2024Dec 31, 2024-$59.17M–
FY2023Dec 31, 2023-$37.93M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$54.23M–
Q2 FY2026Jun 30, 2026-$35.62M–
Q1 FY2026Mar 31, 2026-$47.85M–
Q4 FY2025Dec 31, 2025-$30.63M–
Q3 FY2025Sep 30, 2025-$22.24M–
Q2 FY2025Jun 30, 2025-$39.24M–
Q1 FY2025Mar 31, 2025-$41.17M–
Q4 FY2024Dec 31, 2024-$19.61M–
Q3 FY2024Sep 30, 2024-$13.96M–
Q2 FY2024Jun 30, 2024-$8.04M–
Q1 FY2024Mar 31, 2024-$17.56M–
Q4 FY2023Dec 31, 2023-$16.11M–

More Upstream Bio figures

See a number that looks wrong?